Physician
DR. Nair Internal Medicine, PLLC
DR. Nair Internal Medicine, PLLC was paid $2.73M by Medicaid between Jan 2018 and Dec 2024, across 97 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 51% of everything it billed.
33Billing provider infoDR. NAIR INTERNAL MEDICINE, PLLC
LOUISVILLE, KY 40258
LOUISVILLE, KY 40258
33aNPI1063554608assigned 02/12/2007
33bProvider typeInternal Medicine Physician
28Total paid$2.73M
24GClaims127,880
24DCodes billed97
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in Kentucky
Rank by total paid#12 of 231
Median peer was paid$77K
This provider vs. median36×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13,894 | $340K | |
| 2019 | 15,304 | $342K | |
| 2020 | 11,204 | $354K | |
| 2021 | 18,532 | $400K | |
| 2022 | 21,774 | $458K | |
| 2023 | 28,492 | $462K | |
| 2024incomplete | 18,680 | $380K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 51% | 29,366 | 25,273 | $1.39M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 16% | 13,824 | 12,091 | $436K |
| 99490 | Ccm add 20min | 15% | 15,439 | 14,457 | $400K |
| 99350 | Prolong home eval add 15m | 3.6% | 1,787 | 1,405 | $99K |
| 99439 | 3.2% | 3,446 | 3,257 | $89K | |
| 99349 | 1.6% | 1,726 | 1,061 | $44K | |
| 99442 | 1.2% | 643 | 586 | $33K | |
| 99497 | <1% | 623 | 533 | $26K | |
| 99401 | <1% | 1,435 | 1,238 | $25K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,637 | 1,343 | $24K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 335 | 267 | $24K |
| 99407 | <1% | 926 | 816 | $17K |
85 more codes
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 161 | $12K |
| 99457 | <1% | 697 | $12K | |
| 92587 | <1% | 570 | $11K | |
| 99454 | <1% | 531 | $10K | |
| 94010 | <1% | 376 | $7K | |
| 99354 | <1% | 499 | $6K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 98 | $6K |
| 99408 | <1% | 165 | $6K | |
| 99443 | <1% | 99 | $5K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 383 | $4K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 146 | $4K |
| 76981 | <1% | 71 | $4K | |
| 99344 | <1% | 36 | $3K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 45 | $3K |
| 99441 | <1% | 87 | $3K | |
| 99417 | Prolong home eval add 15m | <1% | 217 | $3K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 220 | $3K |
| 99406 | <1% | 571 | $3K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 101 | $2K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 27 | $2K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 16 | $2K |
| 96103 | <1% | 129 | $2K | |
| 96127 | <1% | 536 | $2K | |
| 99348 | <1% | 41 | $1K | |
| 99345 | Prolong home eval add 15m | <1% | 26 | $1K |
| 90836 | <1% | 35 | $1K | |
| 82044 | <1% | 242 | $906.08 | |
| 93000 | <1% | 57 | $777.09 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 18 | $758.16 |
| 73630 | <1% | 62 | $730.57 | |
| G0318 | Prolonged home or residence evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99345, 99350 for home or residence evaluation and management services). (do not report g0318 on the same date of service as other prolonged services for evaluation and management 99358, 99359, 99417). (do not report g0318 for any time unit less than 15 minutes) | <1% | 369 | $724.23 |
| 82570 | <1% | 192 | $646.42 | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 196 | $604.24 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 110 | $522.48 |
| 81003 | <1% | 740 | $484.70 | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 604 | $471.32 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 34 | $469.49 |
| 96146 | <1% | 236 | $341.67 | |
| 81002 | <1% | 96 | $197.14 | |
| 99453 | <1% | 43 | $174.25 | |
| 11721 | <1% | 24 | $156.84 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 31 | $117.76 |
| 99305 | <1% | 43 | $65.66 | |
| 1125F | <1% | 8,261 | $21.83 | |
| 3008F | <1% | 11,564 | $21.41 | |
| 3044F | <1% | 266 | $20.57 | |
| 1126F | <1% | 3,417 | $11.20 | |
| 3074F | <1% | 2,450 | $6.75 | |
| 3078F | <1% | 2,419 | $6.41 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 11,720 | $3.93 |
| 3079F | <1% | 1,214 | $2.68 | |
| 3077F | <1% | 1,162 | $1.63 | |
| 3075F | <1% | 440 | $0.92 | |
| 3080F | <1% | 502 | $0.43 | |
| 3048F | <1% | 78 | $0.08 | |
| 1034F | <1% | 264 | $0.06 | |
| 1160F | <1% | 246 | $0.02 | |
| 1159F | <1% | 155 | $0.02 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 786 | $0.00 |
| 2010F | 0% | 213 | $0.00 | |
| G8599 | Aspirin or another antiplatelet therapy not used, reason not given | 0% | 53 | $0.00 |
| 4000F | 0% | 492 | $0.00 | |
| 1123F | 0% | 42 | $0.00 | |
| G8432 | Depression screening not documented, reason not given | 0% | 112 | $0.00 |
| 2001F | 0% | 46 | $0.00 | |
| 99308 | Subsequent nursing facility care, per day, straightforward | 0% | 28 | $0.00 |
| G2204 | Patients between 45 and 85 years of age who received a screening colonoscopy during the performance period | 0% | 14 | $0.00 |
| G8970 | No risk factors or one moderate risk factor for thromboembolism | 0% | 14 | $0.00 |
| G8924 | Spirometry results documented (fev1/fvc < 70%) | 0% | 13 | $0.00 |
| 3049F | 0% | 18 | $0.00 | |
| G9664 | Patients who are currently statin therapy users or received an order (prescription) for statin therapy | 0% | 13 | $0.00 |
| 3089F | 0% | 144 | $0.00 | |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | 0% | 59 | $0.00 |
| 888888 | 0% | 388 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 225 | $0.00 |
| 3725F | 0% | 243 | $0.00 | |
| 3023F | 0% | 40 | $0.00 | |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 407 | $0.00 |
| 3046F | 0% | 45 | $0.00 | |
| G9928 | Fda-approved anticoagulant not prescribed, reason not given | 0% | 14 | $0.00 |
| 4025F | 0% | 44 | $0.00 | |
| 3045F | 0% | 45 | $0.00 | |
| 4013F | 0% | 14 | $0.00 | |
| 3050F | 0% | 17 | $0.00 | |
| 1124F | 0% | 26 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialNAIR, SURESH (OWNER/PROVIDER)